作者
Rusheng Chew, Sarah Jongbloed, Dev Jegatheesan, Helen Healy, Kim Ta, Jacobus Ungerer, Peter Donovan, Marion L Woods
发表日期
2016/12/1
期刊
Open Forum Infectious Diseases
卷号
3
期号
suppl_1
页码范围
1983
出版商
Oxford University Press
简介
Background. Ethambutol is renally cleared, but whether it is removed by haemodialysis is uncertain. No consensus guidelines exist on dosing ethambutol in the haemodialysis-dependent patient despite the potential for toxicity, in particular optic neuritis. To address this problem and ascertain if ethambutol is dialysable, we measured serum ethambutol levels in such a patient. We aimed for a trough (pre-dialysis) level of< 1000 µg/l, and a peak level of 2000–6000 µg/l.
Methods. A 79-year-old Caucasian male was diagnosed with delayed disseminated Bacille Calmette-Guérin infection (BCG) secondary to intravesical BCG immunotherapy for bladder cancer 12 months prior. He was on thrice-weekly haemodialysis. Rifampicin, isoniazid and ethambutol were commenced for 6 months, with cessation of ethambutol after 2 months. Ethambutol was dosed post-dialysis. Levels were taken at 0, 1, 2, and 3 hours into a 4-hour …
学术搜索中的文章
R Chew, S Jongbloed, D Jegatheesan, H Healy, K Ta… - Open Forum Infectious Diseases, 2016